ANTX
#3591
AN2 Therapeutics, Inc. - Common Stock
5.5 8 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.79%
Changement Mensuel
+10.93%
Evolution sur 6 mois
+407.27%
Changement Annuel
+398.21%
Clôture Précédente
5.7 4
Open
5.5 8
Low
5.5 8
High
5.5 8
Volume
15
Financials
- Market Capitalization 210.57 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3588 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.92 USD | -3.63% | -7.89% | +37.74% | +116.30% | 211.17 M USD | ||
| 3589 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 10.91 USD | -1.98% | +6.96% | +22.58% | -34.28% | 211.01 M USD | ||
| 3592 |  IMUX Immunic, Inc. - Common Stock | 15.40 USD | -5.52% | -6.55% | +18.46% | +1778.05% | 210.12 M USD | ||
| 3594 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 5.03 USD | -1.37% | +4.57% | +25.75% | +135.05% | 209.23 M USD |